CClinicalTrials.gg
CompletedNCT03816709Updated May 27, 2021Results posted

Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound

An interventional study of Therapeutic Ultrasound in Ultrasound Therapy; Complications, sponsored by North Dakota State University. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-27.

Sponsored by North Dakota State University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be inserted at 1.0, 1.75, and 2.5 cm depths to determine the heating rates. Most modality textbook recommendations for therapeutic ultrasound are based on studies performed with the Omnisound ultrasound machine. Previous research has shown variations in power output across manufacturers, producing differences in tissue temperature increases. No information has been published regarding the heating rates of the Chattanooga Intelect Legend XT machine for ultrasound treatments. By determining the heating rates for this machine, clinicians will be better able to utilize the Chattanooga Intelect Legend XT to help reach therapeutic goals.

Read the detailed description

Individual subjects will report to the research lab. They will be instructed to wear appropriate shorts or pants that can be rolled up to expose the gastrocnemius (calf) muscle. The subject will lay prone on the treatment table with the foot and lower leg off of the treatment table in a relaxed, comfortable position. The following procedures will be completed using universal precautions:

  1. The investigator will prep the treatment area by having the subject flex the calf to determine the proper location for the ultrasound treatment in the middle of the medial gastrocnemius muscle belly at its largest girth.

    1. A carpenter's square with markings along the vertical arm at the three experimental depths (1.0, 1.75, 2.5 cm) will be used.
    2. The horizontal arm of the carpenter's square will be covered in tape. The carpenter's square is then placed just proximal to the treatment mark while the level on the horizontal arm is used to maintain a level measure.
    3. Marks will be made on the muscle belly parallel to the marks on the vertical axis at 1.0, 1.75 and 2.5 cm depths.
    4. A mark is also made on the horizontal arm tape in line with the treatment mark on the medial gastrocnemius.
  2. The Terason uSmart 3300 diagnostic ultrasound unit will be used to measure the adipose thickness over the treatment area and look for abnormalities in the treatment and thermocouple insertion areas. Aquasonic® 100 ultrasound gel will be placed on the 15L4 transducer. The transducer with gel will be placed over the mark of the treatment area. Once the transducer is in place, the screen will be frozen and the skin and adipose thickness will be measured using the caliper tool.
  3. The thermocouples will be removed from the MetriCide after sterilizing for a minimum of 12 hours prior to insertion.

    1. The distal aspect of the thermocouple will be wiped dry with sterile gauze.
    2. A mark with a sharpie will be made on each thermocouple just past the length marked on the horizontal arm of the carpenter's square. This allows the tip of each thermocouple to be directly below the treatment site. A second mark will be made at 5 cm to make sure the thermocouple does not go too deep into the tissue.
    3. The distal end of the thermocouple will be wiped clean again using a 70% isopropyl alcohol wipe up to the marks and then the thermocouple will be wrapped in sterile gauze until it is inserted.
  4. The insertion areas will be shaved to remove any body hair (if necessary) and cleaned using Betadine.

    a. Once the Betadine dries, 70% isopropyl alcohol will be wiped over the insertion area and given time to dry.

  5. The subject will be instructed to take two deep breaths, while the researcher lightly grasps the gastrocnemius to confirm muscle relaxation.

    1. During the second exhalation, the 1.16 in needle catheter will be placed into the subject's calf at the 1.0 cm depth insertion mark using the level to guide the needle in. The needle will be removed leaving the catheter in the tissue.
    2. The thermocouple will be threaded through the catheter to the appropriate depth marked on the thermocouple and the catheter will be removed.
    3. The thermocouple will be secured using medical tape to keep it from moving.
    4. This procedure will be performed 3 times, with one thermocouple placed at each respective depth: 1.0 cm, 1.75 cm, and 2.5 cm.
  6. Each thermocouple will be attached to the Iso Thermex electronic thermometer (Columbus Instruments, Columbus, OH), which will measure and record intramuscular temperatures from the tips of the thermocouples.
  7. An ultrasound treatment template will be applied at the treatment site and secured with tape to maintain consistent treatment size.

    a. This template will be twice the size of the transducer's Effective Radiating Area (ERA).

  8. A metronome will be utilized to consistently move the transducer at a rate of 4 cm/s .
  9. The ultrasound treatment will begin once the intramuscular temperature has remained the same for a minute.
  10. Each subject will receive one ultrasound treatment at the following parameters: 3 MHz frequency, 1.0 W/cm2 intensity, and 100% duty cycle using the Chattanooga Intelect® Legend XT.

    a. Termination of treatment will result when any of the following occur: i. A 15-minute treatment time is obtained. ii. A 4°C temperature increase occurs at all three depths as this has been shown as the necessary temperature change to increase tissue extensibility.

    iii. A 45°C temperature is reached at any depth, due to concern of tissue damage at high temperatures.

    iv. The subject experiences any pain or discomfort during the treatment.

  11. Following the treatment, the ultrasound gel will be wiped from the leg, the template and thermocouples will be removed, and the insertion sites will be cleaned with 70% isopropyl alcohol wipes and covered with a band aid.
  12. The subject will then be instructed on the possibility of minor soreness for the next day or two and instructed on an icing schedule to decrease discomfort.
02

Conditions studied

  • Ultrasound Therapy; Complications

Keywords

  • heating rates
  • therapeutic ultrasound
03

In context

Lead sponsor

North Dakota State University is the lead sponsor of 21 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • males and females between the ages of 18 - 35 years old
  • able to speak English
  • have less than 1 cm of adipose over the left medial gastrocnemius muscle.

Exclusion criteria

Exclusion Criteria:

  • any current lower extremity injury
  • any lower extremity injuries within the last 6 months
  • open wounds
  • skin infections
  • impaired circulation
  • peripheral vascular disease
  • deep vein thrombosis
  • advanced arthritis
  • poor thermal regulation
  • anesthetic areas
  • neoplasms/tumors
  • thrombophlebitis
  • closed infections
  • any allergies or sensitivities to betadine
  • any abnormalities observed in the medial gastrocnemius muscle determined by diagnostic ultrasound
  • 1.0 cm or greater adipose over the left medial gastrocnemius muscle.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Other
    Therapeutic ultrasound treatment

    All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.

    Device: Therapeutic Ultrasound

Interventions

  • DeviceTherapeutic Ultrasound

    A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes.

    Also known as: Ultrasound therapy

06

What researchers measure

Primary outcomes

  1. Heating Rate at 1 cm Depth

    A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.

    Time frame: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)

  2. Heating Rate at 1.75 cm Depth

    A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.

    Time frame: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 8 minutes)

  3. Heating Rate at 2.5 cm Depth

    A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.

    Time frame: Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which did not occur in the 15 minute treatment)

07

Results

Posted May 27, 2021

Participant flow

Twenty-five subjects were recruited through the Institution's Listserve from January-February, 2019.

Participant flow — Overall Study
MilestoneTherapeutic Ultrasound Treatment
Started25
Completed25
Not completed0

Outcome measures

PrimaryHeating Rate at 1 cm Depth

A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.

Time frame:
Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)
Reported as:
Mean · degrees Celcius
Heating Rate at 1 cm Depth
degrees CelciusTherapeutic Ultrasound Treatment
Heating Rate at 1 cm Depth6.49 ± 1.24
PrimaryHeating Rate at 1.75 cm Depth

A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.

Time frame:
Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 8 minutes)
Reported as:
Mean · degrees Celcius
Heating Rate at 1.75 cm Depth
degrees CelciusTherapeutic Ultrasound Treatment
Heating Rate at 1.75 cm Depth5.50 ± 1.34
PrimaryHeating Rate at 2.5 cm Depth

A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.

Time frame:
Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which did not occur in the 15 minute treatment)
Reported as:
Mean · degrees Celcius
Heating Rate at 2.5 cm Depth
degrees CelciusTherapeutic Ultrasound Treatment
Heating Rate at 2.5 cm Depth3.07 ± 1.53

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Therapeutic Ultrasound Treatment0/25 (0%)0/25 (0%)0/25 (0%)

Baseline characteristics

male and female 18-35 year olds with no injuries to the lower leg.

Age, Categorical
Age, Categorical(Participants)Therapeutic Ultrasound Treatment
<=18 years0
Between 18 and 65 years25
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Therapeutic Ultrasound Treatment
Female14
Male11
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Therapeutic Ultrasound Treatment
Region of Enrollment
Region of Enrollment(participants)Therapeutic Ultrasound Treatment
United States25
08

Study locations

1 site
  • North Dakota State University
    Fargo, North Dakota 58108-6050, United States
09

References and documents

Publications

  • Gange KN, Kjellerson MC, Berdan CJ. The Dynatron Solaris(R) Ultrasound Machine: Slower Heating Than Textbook Recommendations at 3 MHz, 1.0 W/cm2. J Sport Rehabil. 2018 Jan 1;27(1):22-29. doi: 10.1123/jsr.2016-0173. Epub 2018 Jan 18. PubMed 27992304 ↗
  • Merrick MA, Bernard KD, Devor ST, Williams MJ. Identical 3-MHz ultrasound treatments with different devices produce different intramuscular temperatures. J Orthop Sports Phys Ther. 2003 Jul;33(7):379-85. doi: 10.2519/jospt.2003.33.7.379. PubMed 12918863 ↗
  • Draper DO, Castel JC, Castel D. Rate of temperature increase in human muscle during 1 MHz and 3 MHz continuous ultrasound. J Orthop Sports Phys Ther. 1995 Oct;22(4):142-50. doi: 10.2519/jospt.1995.22.4.142. PubMed 8535471 ↗

Study documents

  • Study protocol · Jan 22, 2019
  • Statistical analysis plan · Jan 22, 2019
  • Informed consent form · Jan 22, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Once the data has been analyzed to determine the heating rates, a manuscript including the heating rates will be submitted for publication.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03816709
Lead sponsor
North Dakota State University
Responsible party
Kara Gange (Associate Professor, North Dakota State University) — Principal investigator
First posted
Jan 25, 2019
Start date
Feb 5, 2019
Primary completion
Apr 15, 2020
Completion
May 11, 2020
Results posted
May 27, 2021
Last update
May 27, 2021

Study contacts

Kristy Shirley
study director · NDSU IRB

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion